Prabhudas Lilladher's research report on Clean Science and Technology
Clean Science and Technology (CLEAN) reported a revenue of Rs2.2bn (+19.1% YoY, -1.5% QoQ) in Q1FY25. YoY growth was driven by increased volume across all segments. The company does not expect an increase in realization for the next 2-3 quarters. HALS monthly sales are at ~120mt; the plant is operating at less than 20% utilization. The management expects this to reach 200mt by the year end. Three new HALS products were commercialized in Jul’24, with the fourth expected in Aug’24. On the capex front, two new projects have been announced for the Performance Chemical segment, with a total investment of Rs3bn. The pharma intermediate plant is on track and is expected to be commercialized in Q3FY25. New products such as DCC and TBHQ are progressing well, with new clients being onboarded.
Outlook
The company maintains a unique position with niche offerings, sustaining an EBITDM of 42%, supported by new products. Currently, CLEAN trades at 46x FY26 EPS and appears richly valued. We maintain a ‘Hold’ rating with a target price of Rs1,516, valuing the company at 45x FY26 EPS.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
